CLINICAL_TRIALS
withdrawal
· 2024-01-11
Clinical Trial Update: Midodrine in the Recovery Phase of Septic Shock [Phase 3]
Summary
A Phase 3 clinical trial of midodrine in the recovery phase of septic shock was withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Virginia | Conditions: Septic Shock | Phase 3 | Status: WITHDRAWN